Glaukos Announces Participation in the William Blair Growth Stock Conference
businesswire.com
news
2022-06-02 00:00:00

June 02, 2022 07:00 AM Eastern Daylight Time SAN CLEMENTE, Calfi.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the William Blair 42nd Annual Growth Stock Conference on Wednesday, June 8, 2022, at 8:40 a.m. CT in Chicago, IL.

A live and archived webcast for this event will be available in the Investors section of the Glaukos website at http://investors.
